The study concluded that elderly lung cancer patients treated with this combination therapy have no higher risk of death than younger patients. Two and five-year survival rates and disease progression rates for patients 70 and older were not significantly different than those for patients younger than 70
Dear readers! Please observe community rules and respect each other. We do not practice censorship. However, all offensive comments will be deleted, and their posters will be blocked.
Turkey refuses to terminate the deal with Russia for the supply of S-400 anti-aircraft missile systems, Turkish President, Recep Erdogan said